Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Retina Clinic London is a premier private ophthalmology institution and clinical research center specializing in the diagnosis and treatment of complex retinal and vitreous diseases. Led by Professor Paulo Eduardo Stanga, the clinic serves as a global center of excellence for retinal innovation, integrating advanced multimodal imaging, artificial intelligence, and robotic-assisted surgery into daily practice. The clinic is a major site for international clinical trials, collaborating with leading biotechnology and pharmaceutical companies to evaluate next-generation therapies, including gene therapies and novel biologics for conditions such as geographic atrophy and diabetic retinopathy. Its comprehensive services include an on-site operating theatre and a dedicated research department focused on pioneering new treatment protocols and diagnostic technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retina Clinic.